Adelaide RNA

Welcome to the Adelaide RNA Innovation Hub

At the University of Adelaide, our cutting‐edge RNA Innovation Hub is dedicated to advancing RNA science into tangible solutions that advance human health.

Adelaide RNA focuses on transforming RNA research into breakthrough solutions for infectious diseases, cancer immunotherapy, gene therapy and beyond. We leverage our capabilities and interdisciplinary expertise in nanotechnology, advanced manufacturing and analytics to enhance mRNA delivery and optimise therapeutic targeting, ensuring that our innovations address global healthcare challenges.

Our research and innovation

  • Next-generation vaccines

    Our team pioneers the development of mRNA vaccines targeting a range of infectious diseases and emerging pathogens.

  • Biomaterials & immune engineering

    By leveraging biomaterial engineering and nanotechnology, we develop mRNA-based therapeutics designed to enhance cancer immunotherapy and gene therapy.

  • Innovative drug delivery

    Our research in bioinspired nanomaterials and biomimetic devices aims to revolutionise drug delivery systems for RNA.

  • Advanced manufacturing & analytics

    Our experts lead in the manufacturing, purification, and analytics of mRNA and plasmid DNA, ensuring precision and scalability for clinical applications.

  • Molecular & cellular insights

    We explore the molecular virology of positive-sense RNA viruses and the complex cellular interactions that underpin viral infections and host responses.

  • Translational & clinical applications

    We are committed to translating discoveries into effective clinical solutions, from RNA splicing in brain development to mRNA-mediated targeting strategies in cancer.

Research expertise

For information or enquiries on our research, please see the our researchers page. 

For business development and partnering opportunities, please contact the Business Development Team.

For media enquiries, please contact the Media Team.